IngredientID 27980

Notoginsenoside fc

C58H98O26

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Herb: 3Ingredient: 1Target: 2Links: 5
Arranging relationship network...

Record Fields

Scalar fields from the final ingredient record.

Ingredient Id
27980
Core Entity Id
34286
Source Entity Count
1
Preferred Name
Notoginsenoside fc
Name En
Pubchem Id
131751615
Smiles Canonical
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@@](O[C@]2([H])O[C@]([H])(C([H])([H])O[C@]3([H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@ ]3([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]45C([H])([H])[H])[C@@]5(C([H])([H] )[H])C([H])([H])C6([H])[H])[C@@]6([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[C@]7([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]7([H])O[C@]8([H])O[C@]([H])(C([H])([H])O[H])[ C@@]([H])(O[H])[C@]([H])(O[H])[C@@]8([H])O[C@]9([H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]9([H])O[H]
Molecular Formula
C58H98O26
Molecular Weight
1211.3960
Inchikey
XBGLCVZQMWKHFC-UHFFFAOYSA-N
Inchi
InChI=1S/C58H98O26/c1-24(2)10-9-14-58(8,84-51-46(74)41(69)40(68)31(80-51)23-77-49-44(72)36(64)27(62)21-75-49)25-11-16-57(7)35(25)26(61)18-33-55(5)15-13-34(54(3,4)32(55)12-17-56(33,57)6)81-52-47(42(70)38(66)29(19-59)78-52)83-53-48(43(71)39(67)30(20-60)79-53)82-50-45(73)37(65)28(63)22-76-50/h10,25-53,59-74H,9,11-23H2,1-8H3/t25-,26+,27+,28+,29+,30+,31+,32-,33+,34-,35-,36-,37-,38+,39+,40+,41-,42-,43-,44+,45+,46+,47+,48+,49-,50-,51-,52-,53-,55-,56+,57+,58-/m0/s1
Isomeric Smiles
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)C)C)O)C)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)O)O)O)C
Cas Id
88100-04-3
Ob Score
29.6920
Mol Logp
-3.1002
Num H Donors
16
Num H Acceptors
26
Num Rotatable Bonds
17
Drug Likeness
0.0510
Polar Surface Area
416.0000
Molecular Volume
815.0000
Alogp
-2.0000

Names

Preferred names, aliases, and source labels retained in the final schema.

Name
Notoginsenoside Fc_Qt
Role
Molecule_name
Source
SymMap_v2
Preferred
Yes
Name
Notoginsenoside Fc
Role
preferred
Source
SymMap_v2
Preferred
Yes
Name
Notoginsenoside Fc_Qt
Role
preferred
Source
SymMap_v2
Preferred
Yes
Name
Notoginsenoside Fc_qt
Role
preferred
Source
TCMBank
Preferred
Yes
Name
Notoginsenoside fc
Role
preferred
Source
itcmdb_public
Preferred
Yes
Name
Notoginsenoside fc
Role
preferred
Source
HERB_v2
Preferred
Yes
Name
Notoginsenoside fc_qt
Role
preferred
Source
HERB_v2
Preferred
Yes
Name
Notoginsenoside fc_qt
Role
preferred
Source
itcmdb_public
Preferred
Yes
Name
notoginsenoside Fc
Role
preferred
Source
ETCM_v2
Preferred
Yes
Name
notoginsenoside Fc
Role
preferred
Source
TCMBank
Preferred
Yes
Name
三七
Role
TCM_name
Source
TCMBank
Preferred
No
Name
Panax notoginseng
Role
TCM_name_en
Source
TCMBank
Preferred
No
Name
88122-52-5
Role
alias
Source
itcmdb_public
Preferred
No
Name
88122-52-5
Role
alias
Source
HERB_v2
Preferred
No
Name
AC-34758
Role
alias
Source
HERB_v2
Preferred
No
Name
AC-34758
Role
alias
Source
itcmdb_public
Preferred
No
Name
AKOS030530158
Role
alias
Source
HERB_v2
Preferred
No
Name
AKOS030530158
Role
alias
Source
itcmdb_public
Preferred
No
Name
DA-56273
Role
alias
Source
HERB_v2
Preferred
No
Name
DA-56273
Role
alias
Source
itcmdb_public
Preferred
No
Name
DTXSID301316021
Role
alias
Source
itcmdb_public
Preferred
No
Name
DTXSID301316021
Role
alias
Source
HERB_v2
Preferred
No
Name
HY-N2531
Role
alias
Source
HERB_v2
Preferred
No
Name
HY-N2531
Role
alias
Source
itcmdb_public
Preferred
No
Name
MS-32053
Role
alias
Source
HERB_v2
Preferred
No
Name
MS-32053
Role
alias
Source
itcmdb_public
Preferred
No
Name
Notoginsenoside Fa_qt
Role
alias
Source
itcmdb_public
Preferred
No
Name
Notoginsenoside Fa_qt
Role
alias
Source
TCMBank
Preferred
No
Name
Notoginsenoside Fa_qt
Role
alias
Source
HERB_v2
Preferred
No
Name
NotoginsenosideFc
Role
alias
Source
HERB_v2
Preferred
No
Name
notoginsenoside-Fc
Role
alias
Source
itcmdb_public
Preferred
No
Name
7.止血药(25-26)
Role
level1_name
Source
TCMBank
Preferred
No
Name
hemostatic medicinal
Role
level1_name_en
Source
TCMBank
Preferred
No
Name
2.化瘀止血药(5-5)
Role
level2_name
Source
TCMBank
Preferred
No
Name
stasis-resolving hemostatic medicinal
Role
level2_name_en
Source
TCMBank
Preferred
No

Aliases

Additional names normalized into the restored final schema.

Notoginsenoside Fc_Qt三七Panax notoginseng88122-52-5AC-34758AKOS030530158DA-56273DTXSID301316021HY-N2531MS-32053Notoginsenoside Fa_qtNotoginsenosideFcnotoginsenoside-Fc7.止血药(25-26)hemostatic medicinal2.化瘀止血药(5-5)stasis-resolving hemostatic medicinal

Cross References

Trusted external identifiers retained for this final record.

Cas
88100-04-3
Herb
HBIN037427HBIN037428
Npass
NPC217738
Tcmid
15814
Tcmsp
MOL006729MOL006730
Sym Map
SMIT08297SMIT08298
Pub Chem
13175161514616006675412556
Tcmbank
TCMBANKIN023801TCMBANKIN040373
Etcm Ingredient
notoginsenoside Fc
Itcmdb Generated
ITX-INGREDIENT-81B8B8FE2EDAITX-INGREDIENT-9E5F979D8646

Attributes

Merged source attributes and domain-specific metadata.

Type
Other ingredients
Alog P
-2
In Ch I
InChI=1S/C58H98O26/c1-24(2)10-9-14-58(8,84-51-46(74)41(69)40(68)31(80-51)23-77-49-44(72)36(64)27(62)21-75-49)25-11-16-57(7)35(25)26(61)18-33-55(5)15-13-34(54(3,4)32(55)12-17-56(33,57)6)81-52-47(42(70)38(66)29(19-59)78-52)83-53-48(43(71)39(67)30(20-60)79-53)82-50-45(73)37(65)28(63)22-76-50/h10,25-53,59-74H,9,11-23H2,1-8H3/t25-,26+,27+,28+,29+,30+,31+,32-,33+,34-,35-,36-,37-,38+,39+,40+,41-,42-,43-,44+,45+,46+,47+,48+,49-,50-,51-,52-,53-,55-,56+,57+,58-/m0/s1
Mol Wt
1211.396000000001
Cas Id
88100-04-3
Smiles
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@@](O[C@]2([H])O[C@]([H])(C([H])([H])O[C@]3([H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@ ]3([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]45C([H])([H])[H])[C@@]5(C([H])([H] )[H])C([H])([H])C6([H])[H])[C@@]6([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[C@]7([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]7([H])O[C@]8([H])O[C@]([H])(C([H])([H])O[H])[ C@@]([H])(O[H])[C@]([H])(O[H])[C@@]8([H])O[C@]9([H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]9([H])O[H]
37 Flag
37
C Count
58
Mol Log P
-3.100199999999988
N Count
0
O Count
26
P Count
0
S Count
0
Version
v1,v2
In Ch Ikey
XBGLCVZQMWKHFC-NMQALWILSA-N
Ob Score
29.69229.69203729.692037477.1897.189389284
Suppress
0
Tcm Name
三七
Mol2 Path
/TCM_database/7.止血药(25-26)/2.化瘀止血药(5-5)/三七/structure/notoginsenoside Fc.mol2
Reference
4647
Num Hdonors
16
Tcm Name En
Panax notoginseng
Level1 Name
7.止血药(25-26)
Level2 Name
2.化瘀止血药(5-5)
Num H Donors
16
Drug Likeness
0.051
Num Hacceptors
26
Level1 Name En
hemostatic medicinal
Level2 Name En
stasis-resolving hemostatic medicinal
Isomeric Smiles
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)C)C)O)C)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)O)O)O)C
Molecule Weight
1241.59460.82
Num H Acceptors
26
Canonical Smiles
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(CO7)O)O)O)C)C)O)C)OC8C(C(C(C(O8)COC9C(C(C(CO9)O)O)O)O)O)O)C
Herb Alias Names
88122-52-5NotoginsenosideFcnotoginsenoside-FcDTXSID301316021HY-N2531AKOS030530158AC-34758DA-56273MS-32053
Molecular Weight
1210.630
Molecular Volume
815
Molecular Weight
12111241.41
Molecular Formula
C58H98O26
Molecular Formula
C58H98O26C59H100O27
Molecular Formula
C58H98O26C59H100O27
Num Rotatable Bonds
17
Num Rotatable Bonds
17
Molecular Polar Surface Area
416
Fda Maximum Daily Dose (Fdamdd)
0.001
Quantitative Estimate Of Drug Likeness(Qed)
0.051